The U.S. Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and other drugs be tested on animals, saying in a news release that there ...

Discover how advanced detectors are driving improvements in biopharma quality assurance by enhancing precision across ...

FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods and artificial intelligence to determine drug safety and effectiveness.

The MarketWatch News Department was not involved in the creation of this content. TARPON SPRINGS, Fla., August 26, 2025 -- Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR), a ...

The FDA accepted a Priority Review BLA for RP1 and Opdivo in advanced melanoma, with a PDUFA date of July 22, 2025. The BLA is supported by IGNYTE trial data, focusing on patients with anti-PD-1 ...

NG-350A has received FDA fast track designation for mismatch repair-proficient locally advanced rectal cancer, addressing a significant unmet medical need. The drug is an intravenously delivered ...